Skip to main content
. 2022 Apr 28;12:866293. doi: 10.3389/fonc.2022.866293

Table 2.

Expression profiles for ER of IHC results and CTCs, and available PFS and DCR information in the subgroup of patients with available primary tumor IHC results.

Primary Number PFS (range/median) Disease control rate (DCR%)
Biopsy ER+ & CTC ER+ 24 1-7/4 79.2
Biopsy ER+ & CTC ER- 8 1-9/3 37.5
Biopsy ER- & CTC ER+ 3 2-17/5 66.7
Biopsy ER- & CTC ER- 5 1-8/2 20